期刊文献+

IL-12联合IL-2在伯氏疟原虫红内期感染中的免疫调节作用 被引量:4

Regulation of the Immune Responses to Blood-Stage P. berghei Infection by the Combine Treatment with IL-12 and IL-2
下载PDF
导出
摘要 目的探讨IL-12联合IL-2在抗P.berghei红内期感染中的免疫调节作用。方法BALB/c小鼠接种5×105个感染P.berghei的RBC,同时分别给予0.03μg/dIL-12、40U/dIL-2或IL-12联合IL-2处理,连续用药6d,观察小鼠原虫血症变化及存活时间。通过淋巴细胞增殖转化试验、T淋巴细胞亚群测定及NK细胞杀伤活性检测等方法,观察细胞免疫应答水平。结果IL-12联合IL-2处理组可较单独IL-12或单独IL-2及感染对照组显著推迟原虫血症达峰值的时间与明显延长小鼠的存活时间,IL-12或联合IL-2组小鼠在原虫血症达30%时开始死亡,而单独IL-2或感染对照组小鼠在原虫血症低于13%时已全部死亡。IL-12联合IL-2处理组脾淋巴细胞总数、CD4+与CD8+百分比、3H-TdR掺入量及NK细胞杀伤活性均较其它各处理组及感染对照组显著升高。结论IL-12与IL-2二者可协同促进脾淋巴细胞的增殖及增强NK细胞杀伤活性以诱导抗P.berghei红内期感染的免疫保护作用。 Objective To study the combined effects of IL-12 and IL-2 on the development of protective immunity to blood-stage P.berghei. Methods P.berghei infected BALB/e mice were treated with 0.03μg of IL-12 alone or in combination with 40 U of IL-2 once a day for six consecutive days. Parasitemia was monitored and survival time was calculated. Cellular immune responses were elvaulated by lymphocyte proliferation test, CD4^+ and CD8^+ T cells counts and NK cell eytotoxieity. Results Combined treatment with IL-12 and IL-2 could significantly delayed the peak of parasitemia and prolonged survival time of the P.berghei infected mice when compared with the treatment with IL-12 or IL-2 alone. Moreover, the survivalship of the infected mice treated with IL-12 alone or with a eomination of IL-12 and IL-2 started to drop at 30% parasitemia, whereas mice treated with IL-2 alone or without treatment all died before reached 13% of parasitemia. Further, mice received the combine treatment with IL-12 and IL-2 showed significant increases in the numbers of splenic lymphoeytes, the percentages of CD4^+ and CD8^+ T cells, the levels of 3H-TdR incorporation of splenic cells and the activities of NK cells. Conclusion The results indicated that combine treatment with IL-12 and IL-2 could exert synergetie effect on the development of protective immunity to blood-stage P.berghei, probably through the enhancement of lymphocyte proliferation and NK cell eytotoxieity.
出处 《热带医学杂志》 CAS 2005年第6期734-737,755,共5页 Journal of Tropical Medicine
基金 江苏省自然科学基金(No.BK97157)。
关键词 IL-12 IL-2 伯氏疟原虫 红内期 免疫调节 interleukin-12 interleukin-2 P.berghei blood-stage immuregulatory
  • 相关文献

参考文献8

  • 1陈姝,陆惠民,张山鹰,高琪,唐学恒,孙臻安.白细胞介素12在伯氏疟原虫红细胞内期感染中的免疫调节作用[J].海峡预防医学杂志,2004,10(1):1-4. 被引量:5
  • 2Hunter RL, Kidd MR, Olsen MR, et al. Induction of long lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants [J]. J Immunol,1995,154: 1762-1769.
  • 3苏燎原 刘克良 刘芬菊.ConA 诱导淋巴细胞功能研究[J].中华微生物学和免疫学杂志,1986,6(2):71-75.
  • 4方政,余新炳,刘彦文,罗树红.恶性疟原虫FCC1/HN株CSP抗原基因表达产物在小鼠体内的免疫应答研究[J].中国寄生虫学与寄生虫病杂志,1999,17(6):325-329. 被引量:4
  • 5Gately MK, Desai BB, Wditzky AG, et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine,IL-12(cytotoxiclymphocytematurationfactor) [J]. J Immunol, 1991,147: 874-882.
  • 6Sobota V, Bubenik J, Simova J, et al. Intratumoral IL-2 gene transfer improves the therapeutic efficacy of IL-12 but not IL-18[J]. Folia Biol,2000,46(5): 191-193.
  • 7Wigginton JM, Wiltrout RH. IL-12/IL-2 combination from bench to beside[J]. Expert Opin Biol Ther, 2002,2(5):513-524.
  • 8Stern AS, Podlaski FJ, Hulmes JD, et al. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells [J]. Proc Natl Acad sci USA, 1990,87 (17): 6808-6812.

二级参考文献16

  • 1[12]Wang ZE, Zheng S, Corry DB, et al. Interferon γ- independent effects of interleukin-12 administered during acute or established infection due to Leishmania major [J]. Proc Natl Acad Sci USA,1994, 91: 12932-12936.
  • 2[13]Orange JS, Wolf SF, Biron CA, et al. Effects of IL-12 on the response and susceptibility to experimental viral infections [J]. J Immunol, 1994, 152: 1253-1264.
  • 3[14]Seder RS, Kelsail BL, Jankovic D, et al. Differential roles for IL12 in the maintenance of immune responses in infectious versus autoimune disease [J]. J Immunol, 1996,157:2745-2748.
  • 4[15]Portielje JE, KruitWH, Schuler M, et al. Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer [J]. Clin Cancer Res, 1999,5(12) ..3983-3989.
  • 5[16]Sedegah M, Finkelman F, Hoffman SL, et al. Interleukin-12 induction of interferon γ-dependent protection against malaria [J].Proc Natl Acad Sci USA, 1994, 91(22) :10700-10702.
  • 6[1]Stevenson MM, Tam MF, Wolf SF, et al. IL-12-induced protection against blood-stage plasmodium chabaudi AS requires IFN-γand TNF-α and occurs via a nitric oxide-dependent mechanism [J].J Immunol, 1995,155: 2545-2556.
  • 7[2]Yoshimoto T, Youeto T, Waki S, et al. Interleukin-12-dependent mechanisms in the clearance of blood-stage murine malaria parasite plasmodium berghei XAT, an attenuated variant of P. berghei NK65 [J]. J Inf Dis, 1998,177:1674-1681.
  • 8[3]Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes [ J]. J Exp Med, 1989, 170: 827-845.
  • 9[4]Chehimi BJ, Start SE, Frank I, et al. Natural killer (NK) cell stimulatory factory increases the cytotoxic Activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients [J]. J Exp Med, 1991, 175: 789-796.
  • 10[5]Robertson MJ, Soiffer RJ, Wolf SF, et al. Response of human natural killer (NK) cell to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF [J]. J Exp Med, 1992,175(3): 779-788.

共引文献7

同被引文献42

  • 1崔晶,王中全.旋毛虫检疫技术及肉类的安全加工方法[J].中国人兽共患病学报,2006,22(9):871-875. 被引量:29
  • 2赵爱华,乔来艳,贾淑珍,寇丽杰,王国治.BCG-CpG-DNA对重组HBsAg的免疫佐剂作用[J].中国生物制品学杂志,2007,20(5):356-358. 被引量:15
  • 3BARRIGA O O.Responses of B-cell to mitogens and antigen in mice receiving isogenic splenocytes from animals treated with Trichinella extracts[J].J Parasitol,1980,66(5):730-734.
  • 4POZLO E.Updating on trichinellosis[J].Parasitol Tody,1994,10(2):44-45.
  • 5Klassen GR,Thiessen JP,Dick TA.Strain-sPecfic 1.7kilobaserepetitive deoxyribonucleic acid sequence family in Trichinellaspiralis[J].Mol Biochem Parasitol,1986,21(3):227-33.
  • 6Zarlenga DS,Al-Yaman F,Minchella DJ,et al.A rePetitiveDNA probe specific for a Nort h American sylvatic genotype ofTrichinella[J].Mol Biochem Parasitol,1991,48(2):131-7.
  • 7La Rosa G,Pozio E,Rossi P,et al.Allozyme analysis ofTrichinellaisolates from various host species and geographical re-gion[J].J Parasitol,1992,78(4):641-6.
  • 8Snyder DE,Zarlenga DS,La Rosa G,et al.Biochemical,bio-logica,and genetic characterization of a sylvaticisolate ofTrichinella[J].J Parasitol,2009,79(3):347-52.
  • 9WHO. World Malaria Report 2010. [OL/R]. http://www. who. int/ malaria / world_ malaria_report_2010 / en / index.html.
  • 10Dhama K, Mahendran M, Gupta PK, et ol. DNA vaccines and their applications in veterinary practice: current perspectives [J]. Vet Res Commun, 2008, 32 (5): 341-356.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部